CA2277407A1 - Comprime comprenant un ains et du misoprostol - Google Patents

Comprime comprenant un ains et du misoprostol Download PDF

Info

Publication number
CA2277407A1
CA2277407A1 CA002277407A CA2277407A CA2277407A1 CA 2277407 A1 CA2277407 A1 CA 2277407A1 CA 002277407 A CA002277407 A CA 002277407A CA 2277407 A CA2277407 A CA 2277407A CA 2277407 A1 CA2277407 A1 CA 2277407A1
Authority
CA
Canada
Prior art keywords
misoprostol
polymer
tablet
core
nsaid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CA002277407A
Other languages
English (en)
Inventor
Bernard Charles Sherman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA002277407A priority Critical patent/CA2277407A1/fr
Priority to US09/614,135 priority patent/US6656503B1/en
Priority to AU47192/00A priority patent/AU776430B2/en
Priority to ES00305965T priority patent/ES2207466T3/es
Priority to ZA200003511A priority patent/ZA200003511B/xx
Priority to DE60005438T priority patent/DE60005438T2/de
Priority to EP00305965A priority patent/EP1068867B1/fr
Priority to AT00305965T priority patent/ATE250411T1/de
Priority to JP2000214392A priority patent/JP2001039876A/ja
Publication of CA2277407A1 publication Critical patent/CA2277407A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
CA002277407A 1999-07-14 1999-07-14 Comprime comprenant un ains et du misoprostol Withdrawn CA2277407A1 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
CA002277407A CA2277407A1 (fr) 1999-07-14 1999-07-14 Comprime comprenant un ains et du misoprostol
US09/614,135 US6656503B1 (en) 1999-07-14 2000-07-11 Pharmaceutical tablet comprising an NSAID and misoprostol
AU47192/00A AU776430B2 (en) 1999-07-14 2000-07-12 Pharmaceutical tablet comprising an NSAID and misoprostol
ES00305965T ES2207466T3 (es) 1999-07-14 2000-07-13 Comprimido farmaceutico que comprende nsaid y misoprostol.
ZA200003511A ZA200003511B (en) 1999-07-14 2000-07-13 Pharmaceutical tablet comprising an nsaid and misoprostol.
DE60005438T DE60005438T2 (de) 1999-07-14 2000-07-13 Ein NSAID und Misoprostol enthaltende Arzneitablette
EP00305965A EP1068867B1 (fr) 1999-07-14 2000-07-13 Comprimé pharmaceutique renfermant un AINS et misoprostol
AT00305965T ATE250411T1 (de) 1999-07-14 2000-07-13 Ein nsaid und misoprostol enthaltende arzneitablette
JP2000214392A JP2001039876A (ja) 1999-07-14 2000-07-14 Ｎｓａｉｄ及びミソプロストールを含む医薬錠剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002277407A CA2277407A1 (fr) 1999-07-14 1999-07-14 Comprime comprenant un ains et du misoprostol

Publications (1)

Publication Number Publication Date
CA2277407A1 true CA2277407A1 (fr) 2001-01-14

Family

ID=4163733

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002277407A Withdrawn CA2277407A1 (fr) 1999-07-14 1999-07-14 Comprime comprenant un ains et du misoprostol

Country Status (9)

Country Link
US (1) US6656503B1 (fr)
EP (1) EP1068867B1 (fr)
JP (1) JP2001039876A (fr)
AT (1) ATE250411T1 (fr)
AU (1) AU776430B2 (fr)
CA (1) CA2277407A1 (fr)
DE (1) DE60005438T2 (fr)
ES (1) ES2207466T3 (fr)
ZA (1) ZA200003511B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6319519B2 (en) 1998-07-07 2001-11-20 Norton Healthcare Ltd. Anti-inflammatory pharmaceutical formulations
US6387410B1 (en) * 1998-09-10 2002-05-14 Norton Healthcare Ltd Anti-inflammatory pharmaceutical formulations
EP1216030A1 (fr) * 1999-10-01 2002-06-26 Norton Healthcare Limited Preparations pharmaceutiques anti-inflammatoires
US20040068014A1 (en) * 2001-02-22 2004-04-08 Yoshiki Sakai Medicinal compositions comprising diclofenac and ornoprostil
DE60237087D1 (de) * 2001-06-01 2010-09-02 Pozen Inc Pharmazeutische zusammensetzungen für die koordinierte abgabe von nsaid
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
AU2003262264A1 (en) * 2002-08-22 2004-03-11 Ono Pharmaceutical Co., Ltd. Agent for reducing side effects of diclofenac
ATE366105T1 (de) * 2003-03-03 2007-07-15 Sprl Franpharma Stabilisierte pharmazeutische zusammensetzung enthaltend einen nsaid und einen prostaglandin
RU2362549C2 (ru) * 2003-09-24 2009-07-27 Новартис Консьюмер Хелс С.А. Таблетки в оболочке
FR2861990B1 (fr) * 2003-11-10 2006-02-10 Nouveaux Produits Pharma Comprimes faiblement doses a reseau de polymeres
US9265732B2 (en) 2006-03-06 2016-02-23 Pozen Inc. Dosage forms for administering combinations of drugs
US20090022786A1 (en) * 2007-07-16 2009-01-22 Yung Shin Pharm. Ind. Co., Ltd. Oral pharmaceutical dosage form and manufacturing method thereof
EP2344139A1 (fr) 2008-09-09 2011-07-20 AstraZeneca AB Procédé d'administration d'une composition pharmaceutique à un patient en ayant besoin
EP2210595A1 (fr) 2009-01-14 2010-07-28 LEK Pharmaceuticals d.d. Revêtement actif de formes de dosage pharmaceutique
EP2445499A4 (fr) 2009-06-25 2013-02-27 Astrazeneca Ab Procede pour le traitement d'un patient a risque de developer un ulcere associe a nsaid
BR112014016085A8 (pt) 2011-12-28 2017-07-04 Pozen Inc composições aprimoradas e métodos para distribuição de omeprazol mais ácido acetilsalicílico
CA2978593A1 (fr) * 2015-01-12 2016-07-21 Nano Pharmaceutical Laboratories Llc Microbilles multicouches a liberation prolongee et leur procedes de fabrication
CN111700872A (zh) * 2020-07-20 2020-09-25 华益药业科技(安徽)有限公司 一种双氯芬酸肠溶片及其加工工艺

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4301146A (en) 1980-07-29 1981-11-17 G. D. Searle & Co. Stabilization of 16-oxygenated prostanoic acid derivatives
AU8089091A (en) * 1990-05-03 1991-11-27 G.D. Searle & Co. Pharmaceutical composition containing ibuprofen and a prostaglandin
EP0527887B1 (fr) 1990-05-03 1995-04-26 G.D. Searle & Co. Composition pharmaceutique
DE4220123A1 (de) * 1991-09-18 1993-04-01 Schering Ag Pharmazeutische praeparate
NZ253999A (en) * 1992-08-05 1996-07-26 Faulding F H & Co Ltd Pelletised substained release medicament

Also Published As

Publication number Publication date
AU4719200A (en) 2001-01-18
DE60005438D1 (de) 2003-10-30
ZA200003511B (en) 2001-02-05
DE60005438T2 (de) 2004-07-08
EP1068867A2 (fr) 2001-01-17
JP2001039876A (ja) 2001-02-13
AU776430B2 (en) 2004-09-09
US6656503B1 (en) 2003-12-02
ES2207466T3 (es) 2004-06-01
ATE250411T1 (de) 2003-10-15
EP1068867A3 (fr) 2001-04-25
EP1068867B1 (fr) 2003-09-24

Similar Documents

Publication Publication Date Title
EP1068867B1 (fr) Comprimé pharmaceutique renfermant un AINS et misoprostol
EP2167048B1 (fr) Nouvelle forme posologique de comprimé
CA2654890C (fr) Composition pharmaceutique
US5593696A (en) Stabilized composition of famotidine and sucralfate for treatment of gastrointestinal disorders
CA2363053C (fr) Formulation pour pastilles de bisulfate de clopidogrel
US5756125A (en) Controlled release naproxen sodium plus naproxen combination tablet
AU2001268719A1 (en) Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates
WO2002000204A1 (fr) Compositions et forme posologique pour liberation gastrique retardee d'alendronate et/ou d'autres bis-phosphonates
US20040076667A1 (en) Sustained release pharmaceutical composition containing metformin hydrochloride
WO2002066002A2 (fr) Composition pharmaceutique
JP2009501785A (ja) 新規な調節放出性医薬製剤シクロオキシゲナーゼ酵素阻害剤
KR20010073172A (ko) 음식물 효과-비의존적으로 방출되는 다중 단위 제약 제제및 그의 제조 방법
NO329940B1 (no) Anvendelse av crospovidon med natriumhydroksyd for a stabilisere rabeprazol
SK169999A3 (en) Controlled release pharmaceutical preparation with ace inhibitor as active agent
US6740340B1 (en) Pharmaceutical tablets comprising an NSAID and a prostaglandin
JPH05255125A (ja) 徐放性製剤およびその製法
CA2259727A1 (fr) Pastille pharmaceutique a deux couches comprenant un ains et du misoprostol
CN114929207A (zh) 利奥西呱的调节释放型药物组合物
EP1216030A1 (fr) Preparations pharmaceutiques anti-inflammatoires
AU2016210691A1 (en) Controlled release formulations of paracetamol
EP4212149A1 (fr) Formes galéniques orales de sel acido-labile et procédés et utilisations associés
WO2000025750A1 (fr) Compositions de metamizole a liberation prolongee
RU2214242C1 (ru) Способ получения таблеток, содержащих симвастатин
WO2008062426A2 (fr) Formulation de dérivés de benzazépine
CA2489572A1 (fr) Comprimes a liberation prolongee contenant du divalproex sodium

Legal Events

Date Code Title Description
EEER Examination request
AZWI Withdrawn application